DK1059933T3 - Anvendelse af parathyroideahormon bestående af aminosyresekvens 1-34 af humant parathyroideahormon til reduktion af risikoen for både hvirvel- og ikke-hvirvel knoglefraktur - Google Patents

Anvendelse af parathyroideahormon bestående af aminosyresekvens 1-34 af humant parathyroideahormon til reduktion af risikoen for både hvirvel- og ikke-hvirvel knoglefraktur

Info

Publication number
DK1059933T3
DK1059933T3 DK99942350T DK99942350T DK1059933T3 DK 1059933 T3 DK1059933 T3 DK 1059933T3 DK 99942350 T DK99942350 T DK 99942350T DK 99942350 T DK99942350 T DK 99942350T DK 1059933 T3 DK1059933 T3 DK 1059933T3
Authority
DK
Denmark
Prior art keywords
parathyroid hormone
vertebral
risk
amino acid
acid sequence
Prior art date
Application number
DK99942350T
Other languages
English (en)
Inventor
Janet M Hock
Gregory A Gaich
Willard H Dere
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1059933(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1059933T3 publication Critical patent/DK1059933T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK99942350T 1998-08-19 1999-08-19 Anvendelse af parathyroideahormon bestående af aminosyresekvens 1-34 af humant parathyroideahormon til reduktion af risikoen for både hvirvel- og ikke-hvirvel knoglefraktur DK1059933T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9715198P 1998-08-19 1998-08-19
US9974698P 1998-09-10 1998-09-10
PCT/US1999/018961 WO2000010596A1 (en) 1998-08-19 1999-08-19 Method of increasing bone toughness and stiffness and reducing fractures

Publications (1)

Publication Number Publication Date
DK1059933T3 true DK1059933T3 (da) 2003-04-07

Family

ID=26792729

Family Applications (4)

Application Number Title Priority Date Filing Date
DK10180447.4T DK2266598T3 (da) 1998-08-19 1999-08-19 Fremgangsmåde til at øge knoglehårdhed og -stivhed og at reducere brud
DK99942350T DK1059933T3 (da) 1998-08-19 1999-08-19 Anvendelse af parathyroideahormon bestående af aminosyresekvens 1-34 af humant parathyroideahormon til reduktion af risikoen for både hvirvel- og ikke-hvirvel knoglefraktur
DK15152726.4T DK2907522T3 (da) 1998-08-19 1999-08-19 Fremgangsmåde til øgning af knoglehårdhed og stivhed og reduktion af frakturer
DK06027055.0T DK1769804T3 (da) 1998-08-19 1999-08-19 hPTH(1-34) til anvendelse ved forebyggelse eller reduktion af forekomsten eller voldsomheden af vertebral og/eller ikke-vertebral fraktur hos en mand

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10180447.4T DK2266598T3 (da) 1998-08-19 1999-08-19 Fremgangsmåde til at øge knoglehårdhed og -stivhed og at reducere brud

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK15152726.4T DK2907522T3 (da) 1998-08-19 1999-08-19 Fremgangsmåde til øgning af knoglehårdhed og stivhed og reduktion af frakturer
DK06027055.0T DK1769804T3 (da) 1998-08-19 1999-08-19 hPTH(1-34) til anvendelse ved forebyggelse eller reduktion af forekomsten eller voldsomheden af vertebral og/eller ikke-vertebral fraktur hos en mand

Country Status (32)

Country Link
US (2) US6977077B1 (da)
EP (3) EP2266598B1 (da)
JP (5) JP2002523375A (da)
KR (1) KR100454207B1 (da)
CN (1) CN1205997C (da)
AR (1) AR033639A1 (da)
AT (1) ATE231000T1 (da)
AU (1) AU746277B2 (da)
BR (1) BR9909445A (da)
CA (1) CA2325371C (da)
CO (1) CO5130020A1 (da)
CY (2) CY1113343T1 (da)
CZ (1) CZ301017B6 (da)
DE (2) DE15152726T1 (da)
DK (4) DK2266598T3 (da)
DZ (1) DZ2873A1 (da)
EA (1) EA003362B1 (da)
ES (4) ES2393200T3 (da)
HR (1) HRP20000755A2 (da)
HU (2) HU230697B1 (da)
ID (1) ID29039A (da)
IL (2) IL138829A0 (da)
MY (1) MY129227A (da)
NO (2) NO323984B1 (da)
NZ (1) NZ507056A (da)
PE (1) PE20001089A1 (da)
PL (1) PL201688B1 (da)
PT (4) PT2907522T (da)
TR (1) TR200003455T2 (da)
TW (1) TW576747B (da)
UA (1) UA72205C2 (da)
WO (1) WO2000010596A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
DZ2873A1 (fr) * 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
WO2001022093A1 (en) * 1999-09-20 2001-03-29 Eli Lilly And Company Method for monitoring treatment with a parathyroid hormone
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
EP1531855A4 (en) * 2002-01-10 2009-07-22 Osteotrophin Llc TREATMENT OF BONE DISEASES WITH SKELETTAL ANABOLIKA
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
KR20060058133A (ko) * 2003-09-19 2006-05-29 화이자 프로덕츠 인코포레이티드 2-알킬리덴-19-노르-비타민 ｄ 유도체 및 부갑상선호르몬의 조합을 포함하는 약학 조성물 및 방법
US20060189533A1 (en) * 2004-05-10 2006-08-24 Nastech Pharmaceutical Company Inc. Stable pharmaceutical dosage forms of teriparatide
CA2567056A1 (en) * 2004-05-10 2005-12-08 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of parathyroid hormone
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US7556821B2 (en) 2004-05-13 2009-07-07 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US7648965B2 (en) 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US20060069021A1 (en) * 2004-08-13 2006-03-30 Nastech Pharmaceutical Company Inc. Compositions and methods for intranasal administration of inactive analogs of PTH or inactivated preparations of PTH or PTH analogs
WO2006073711A2 (en) 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
EP1879608A4 (en) * 2005-05-11 2009-11-11 Unigene Lab Inc METHOD FOR STIMULATING BONE FORMATION AND PRESERVATION
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
CA2628945A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20080119408A1 (en) * 2006-07-07 2008-05-22 Nastech Pharmaceutical Company Inc. Pth formulations for intranasal delivery
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
DK2136850T3 (da) 2007-04-13 2012-04-10 Kuros Biosurgery Ag Polymervævforsegling
US20110137243A1 (en) * 2007-09-06 2011-06-09 Abbott Cardiovascular Systems Inc. Coating On A Balloon Device
US9457056B2 (en) * 2007-12-04 2016-10-04 Ben-Gurion University Of The Negev Research And Development Authority Peptides comprising alternating hydrophobic and anionic amino acids for treatment of osteoporosis
WO2009083544A2 (en) 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
KR20190095552A (ko) * 2009-09-09 2019-08-14 아사히 가세이 파마 가부시키가이샤 1회당 100∼200 단위의 ｐｔｈ가 주 1회 투여되는 것을 특징으로 하는, ｐｔｈ 함유 골다공증 치료/예방제
BR112012013725A2 (pt) 2009-12-07 2017-01-10 Univ Michigan Tech paratormônio de urso preto e métodos de usar o paratormônio de uso preto.
US9295663B2 (en) 2010-07-14 2016-03-29 Abbott Cardiovascular Systems Inc. Drug coated balloon with in-situ formed drug containing microspheres
WO2012111852A1 (ja) * 2011-02-17 2012-08-23 帝人ファーマ株式会社 椎体骨折治療剤及びその評価方法
EP2686027B1 (en) 2011-03-16 2021-05-05 Kuros Biosurgery AG Pharmaceutical formulation for use in spinal fusion
KR20150116467A (ko) 2011-06-07 2015-10-15 아사히 가세이 파마 가부시키가이샤 고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
US9700485B2 (en) 2013-04-24 2017-07-11 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US11492386B2 (en) 2016-02-01 2022-11-08 Eli Lilly And Company Parathyroid hormone-anti-RANKL antibody fusion compounds
US20190381341A1 (en) * 2017-02-01 2019-12-19 The Johns Hopkins University Parathyroid hormone and regeneration of degenerative discs disease
US20200289621A1 (en) * 2017-09-22 2020-09-17 Asahi Kasei Pharma Corporation Teriparatide-containing liquid pharmaceutical composition having excellent stability
ES3009869T3 (en) 2018-10-29 2025-03-31 Asahi Kasei Pharma Corp An improved teriparatide dosage regimen for use in preventing or treating osteoporosis characterized by administering teriparatide or salt thereof twice a week
EP4010360A1 (en) 2019-08-09 2022-06-15 Flagship Pioneering Innovations VI, LLC Modulators of parathyroid hormone receptor (pthr1)
GB2590692A (en) * 2019-12-24 2021-07-07 Corthotec Ltd Composition for improved bone fracture healing

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086196A (en) 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
IL78342A (en) 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
DE3935738A1 (de) 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5208041A (en) 1991-05-23 1993-05-04 Allelix Biopharmaceuticals Inc. Essentially pure human parathyroid hormone
US5556940A (en) 1994-06-20 1996-09-17 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
JPH0873376A (ja) * 1994-09-07 1996-03-19 Asahi Chem Ind Co Ltd 骨粗鬆症治療薬
JPH10511095A (ja) * 1994-12-19 1998-10-27 ベス イスラエル ディーコネス メディカル センター インコーポレイテッド 副甲状腺ホルモン又はその作動薬の低用量継続投与
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
EP1283035A3 (en) * 1994-12-22 2003-03-19 AstraZeneca AB Therapeutic preparation for inhalation containing parathyroid hormone
JPH08310965A (ja) * 1995-05-16 1996-11-26 Chugai Pharmaceut Co Ltd 骨癒合促進剤
HRP20000109A2 (en) * 1997-09-09 2001-02-28 Hoffmann La Roche FRACTURE HEALING USING PTHrP ANALOGS
ZA9811127B (en) 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
DZ2873A1 (fr) * 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
US6907597B1 (en) 2000-10-13 2005-06-14 Ati International Srl Method and apparatus for constructing an executable program in memory
US6967759B2 (en) 2001-12-31 2005-11-22 Texas Instruments Incorporated Pulse width modulation sequence generation
JP5796714B2 (ja) 2012-01-13 2015-10-21 株式会社リコー 定着装置及び画像形成装置
EP2949301B1 (en) 2014-05-27 2018-04-18 The Procter and Gamble Company Absorbent core with curved and straight absorbent material areas

Also Published As

Publication number Publication date
CZ20004134A3 (cs) 2001-08-15
ES2190244T3 (es) 2003-07-16
EA003362B1 (ru) 2003-04-24
DE69904918D1 (de) 2003-02-20
ES2549551T3 (es) 2017-11-27
EP1059933B1 (en) 2003-01-15
EP2907522A1 (en) 2015-08-19
HU1200430D0 (hu) 2001-11-28
NO20072983L (no) 2000-11-24
JP2011021035A (ja) 2011-02-03
HRP20000755A2 (en) 2001-02-28
DK2266598T3 (da) 2017-05-15
EP1059933A1 (en) 2000-12-20
UA72205C2 (uk) 2005-02-15
EA200001015A1 (ru) 2001-02-26
US20050197294A1 (en) 2005-09-08
TW576747B (en) 2004-02-21
JP2017190332A (ja) 2017-10-19
US7163684B2 (en) 2007-01-16
HU230697B1 (hu) 2017-09-28
DE15152726T1 (de) 2015-12-10
CA2325371C (en) 2004-08-17
PT1059933E (pt) 2003-06-30
EP2266598B1 (en) 2017-02-22
EP2266598A1 (en) 2010-12-29
TR200003455T2 (tr) 2001-06-21
PL343595A1 (en) 2001-08-27
DE69904918T2 (de) 2003-11-13
HK1102496A1 (en) 2007-11-23
CN1205997C (zh) 2005-06-15
DK2907522T1 (da) 2015-10-19
DK2907522T3 (da) 2017-10-23
KR20010072763A (ko) 2001-07-31
JP6177718B2 (ja) 2017-08-09
CN1308545A (zh) 2001-08-15
MY129227A (en) 2007-03-30
HUP0101594A3 (en) 2002-01-28
AR033639A1 (es) 2004-01-07
DZ2873A1 (fr) 2003-12-15
CA2325371A1 (en) 2000-03-02
PT2907522T (pt) 2017-10-23
JP2015028065A (ja) 2015-02-12
ID29039A (id) 2001-07-26
PL201688B1 (pl) 2009-04-30
DK1769804T3 (da) 2012-10-15
US6977077B1 (en) 2005-12-20
HUP0101594A2 (hu) 2001-11-28
PT2266598T (pt) 2017-05-02
JP2014139220A (ja) 2014-07-31
IL138829A (en) 2011-01-31
WO2000010596A1 (en) 2000-03-02
AU746277B2 (en) 2002-04-18
JP2002523375A (ja) 2002-07-30
HK1212602A1 (en) 2016-06-17
NZ507056A (en) 2003-10-31
EP2907522B1 (en) 2017-08-02
ES2393200T3 (es) 2012-12-19
PE20001089A1 (es) 2000-11-04
PT1769804E (pt) 2012-11-13
KR100454207B1 (ko) 2004-10-26
NO20005947D0 (no) 2000-11-24
ES2621653T3 (es) 2017-07-04
NO20005947L (no) 2000-11-24
CY1119552T1 (el) 2018-03-07
NO323984B1 (no) 2007-07-30
ATE231000T1 (de) 2003-02-15
IL138829A0 (en) 2001-10-31
AU5575099A (en) 2000-03-14
CY1113343T1 (el) 2016-06-22
CO5130020A1 (es) 2002-02-27
CZ301017B6 (cs) 2009-10-14
ES2549551T1 (es) 2015-10-29
BR9909445A (pt) 2000-12-12
HK1030545A1 (en) 2001-05-11

Similar Documents

Publication Publication Date Title
DK1059933T3 (da) Anvendelse af parathyroideahormon bestående af aminosyresekvens 1-34 af humant parathyroideahormon til reduktion af risikoen for både hvirvel- og ikke-hvirvel knoglefraktur
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
DE59907286D1 (de) Marknagel zur Knochendistraktion
ATA131798A (de) Implantat zur gegenseitigen fixierung zweier knochenfragmente
DE50008238D1 (de) Aktiver marknagel zur distraktion von knochenteilen
AU2002362220A8 (en) Bone fasteners and method for stabilizing vertebral bone facets using the bone fasteners
DE60117664D1 (de) System zur Befestigung von Weichgewebe an Knochen
DK1223927T3 (da) Anvendelse af retigabin til behandling af neuropatiske smerter
FI981916A7 (fi) Menetelmät kudoksen muodostumisen aiheuttamiseksi käyttäen luun morfog eneettisen proteiinin ja lisäkilpirauhashormonin kaltaisen peptidin yh distelmää
ATE294539T1 (de) Knochenfixationssystem
PL339449A1 (en) Treatment of bone fractures involving the use of pthrp analogues
DK1119349T3 (da) Epidermal vækstfaktor receptorantagonister til behandling af voldsomt foröget slimudskillelse i lungerne
EP1567072A4 (en) BONE BREAKING FIXING SYSTEM OPERATING IN MULTIPLE DIRECTIONS AND ACTUATING STABILIZING PINS IN ONE DIRECTION
EP1691699A4 (en) BONE FIXING ARRANGEMENT AND FASTENING METHOD
AU2003271571A8 (en) Surgical nail and screw fixation system
DK1139891T3 (da) Anordning til udvendig fiksering af knoglebrud, især brud på ankelen
DE69930059D1 (de) Blockierungsmechanismus zur Fixierung der Wirbelsäule
EP1246651A4 (en) BIOACTIVE AND EASTOPEROTIC BONE CEMENT
DK0980250T3 (da) Planteekstrakter til behandling af forøget knogleresorption
AU4568901A (en) Vertebral implant for promoting arthrodesis of the spine
IT1296954B1 (it) Chiodo endomidollare per uso in osteosintesi per il trattamento chirurgico delle fratture diafisometafisarie di femore e di tibia,
IL166577A0 (en) Radioactively labelled amino acid analogues their preparation and use
FI990126A7 (fi) Paratyreoideahormonianalogeja osteoporoosin hoitoon
AU2003251527A1 (en) Analogs of parathyroid hormone and pth-related protein as bone anabolic agents
WO2005072277A3 (en) Amidated parathyroid hormone fragments and uses thereof